Previously, the suppression of TSPAN32 by the AML-ETO fusion protein has been shown to involve in AML pathogenesis.26 When we ectopically expressed TSPAN32 in Ph+ cell lines, we found that TSPAN32 suppressed cell proliferation and increased TKI susceptibility (Fig. 2). Here, TSPAN32 is linked to acute myeloid leukemia.